Rigetti Computing Is Down 70% From Its High. Time to Buy?

Rigetti reported 2025 revenue of $7.1 million, down 34% year over year, as a delayed 108-qubit Cepheus-1 launch and a paused government contract reauthorization weighed on results. The company posted a $216 million loss in 2025 and negative free cash flow of $77 million, although analysts still forecast 219% revenue growth in 2026 and 103% growth in 2027. Despite the pullback, valuation remains stretched with a P/S ratio above 730, keeping the stock highly speculative.

Analysis

The market is effectively pricing Rigetti as a binary sentiment instrument, not as a cash-flowing business. That creates a reflexive setup where any credible technical milestone or government-contractor reactivation can trigger a violent squeeze, but the underlying economics still look like a dilution machine unless growth accelerates faster than spend. The key second-order effect is that the stock can re-rate on narrative alone before the business model improves, which makes it tradable but not yet investable on fundamentals.

The real beneficiaries are not the named hyperscalers in the article but adjacent quantum-enablement layers: semiconductor tooling, cryogenic infrastructure, and high-frequency measurement/controls vendors that get paid regardless of which quantum architecture wins. If Rigetti’s tiled-chiplet approach proves repeatable, it may pressure competing quantum names to justify much larger capital intensity per incremental qubit, shifting investor preference toward capital-efficient architectures rather than brute-force scale.

The contrarian miss is that the stock is no longer reacting to revenue quality so much as to convexity in expectations. With valuation anchored at an extreme multiple, the upside from a beat is likely to come from multiple expansion on a cleaner roadmap, while downside comes from one or two quarters of dilution or project slippage. Time horizon matters: near-term tradeable upside is a days-to-weeks event on contract/newsflow, but fundamental downside is a 6-18 month grind if the company keeps funding losses through the equity market.

For the broader tape, this is a cautionary read on speculative tech: when a small-cap story stock loses operating momentum, the recovery path is usually not linear. The market may overestimate how quickly a delayed launch converts into recurring revenue; in practice, customers and government agencies re-validate platforms slowly, which can push meaningful monetization out by multiple quarters.

Key Decisions for Investors

• Avoid long-only exposure to RGTI here unless sizing is explicitly event-driven; the stock can re-rate sharply on news, but the carry risk is high because any missed milestone likely forces financing at unfavorable terms over the next 6-12 months.
• For a tactical trade, buy RGTI only on confirmed catalyst headlines and hedge with a defined-risk options structure (e.g., call spread rather than stock) to capture a squeeze while capping the probability of getting trapped in post-rally mean reversion.
• Relative-value: prefer a basket long in quantum picks-and-shovels / enabling infrastructure versus a short or underweight in speculative quantum application names; the revenue stream is less binary and should be less exposed to delayed commercialization.
• If the name is already owned, reduce into strength on any 20-30% gap-up move; in this tape, momentum in microcap growth often decays within 1-3 sessions once the incremental buyer is exhausted.
• Monitor liquidity and any secondary offering risk closely; if balance-sheet cash burn remains near current levels, dilution risk becomes the dominant bear case and can overwhelm any fundamental progress over the next 2-4 quarters.